Cyclo Therapeutics Inc (CYTH)

[octagramt]

OK, so your saying that employee stock compensation was adjusted in a manner that impacted cash flow the same as how depreciation adjustments impact cash flow. Thanks for clearing that up, it's been needling me for some time.

My main point though is that I think CTDH will get attention/more attention and the stock will see held gains once it has positive net income after expenses. I think that can be made achievable with the orphan designation benefits and the c-GMP plant, which means more time needs to pass. With this in mind I'm thinking that a 1-2 year time frame is reasonable.